ERBB2 and breast carcinoma: Among these, ACIS in particular has been used extensively, in the analysis of immunohistochemically stained lung cancer specimens for p53, ki-67, and p120 status [42] as well as HER-2/neu expression in breast cancer by both immunohistochemical staining and fluorescence in-situ hybridization [43-45].